Charles River [CRL] vs Exact Sciences [EXAS] Detailed Stock Comparison
Charles River
NYSE
Loading...
Exact Sciences
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Charles River wins in 15 metrics, Exact Sciences wins in 4 metrics, with 0 ties. Charles River appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Charles River | Exact Sciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 681.33 | -7.33 | Exact Sciences |
| Price-to-Book Ratio | 2.18 | 3.14 | Charles River |
| Debt-to-Equity Ratio | 82.04 | 102.73 | Charles River |
| PEG Ratio | 14.47 | -120.56 | Exact Sciences |
| EV/EBITDA | 10.44 | 120.57 | Charles River |
| Profit Margin (TTM) | -1.66% | -34.19% | Charles River |
| Operating Margin (TTM) | 16.67% | 0.34% | Charles River |
| EBITDA Margin (TTM) | 16.67% | 0.34% | Charles River |
| Return on Equity | -1.81% | -35.51% | Charles River |
| Return on Assets (TTM) | 4.31% | -1.39% | Charles River |
| Free Cash Flow (TTM) | $501.61M | $74.55M | Charles River |
| 1-Year Return | -25.99% | -28.10% | Charles River |
| Price-to-Sales Ratio (TTM) | 1.82 | 2.64 | Charles River |
| Enterprise Value | $9.97B | $9.44B | Charles River |
| EV/Revenue Ratio | 2.48 | 3.21 | Charles River |
| Gross Profit Margin (TTM) | 34.59% | 69.35% | Exact Sciences |
| Revenue per Share (TTM) | $80 | $16 | Charles River |
| Earnings per Share (Diluted) | $-1.29 | $-5.45 | Charles River |
| Beta (Stock Volatility) | 1.48 | 0.93 | Exact Sciences |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Charles River vs Exact Sciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Charles River | -0.69% | -10.89% | -6.09% | 5.22% | -6.97% | -18.56% |
| Exact Sciences | -5.03% | -14.18% | -23.44% | -22.75% | -21.74% | -28.00% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Charles River | -25.99% | -36.17% | -30.65% | 97.58% | 398.29% | 189.66% |
| Exact Sciences | -28.10% | -4.03% | -51.96% | 78.68% | 853.26% | 1,579.92% |
Performance & Financial Health Analysis: Charles River vs Exact Sciences
| Metric | CRL | EXAS |
|---|---|---|
| Market Information | ||
| Market Cap | $7.32B | $7.76B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 989,150 | 4,605,740 |
| 90 Day Avg. Volume | 877,473 | 3,261,747 |
| Last Close | $148.74 | $40.99 |
| 52 Week Range | $91.86 - $230.02 | $38.81 - $72.83 |
| % from 52W High | -35.34% | -43.72% |
| All-Time High | $460.21 (Sep 20, 2021) | $159.54 (Jan 25, 2021) |
| % from All-Time High | -67.68% | -74.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.16% |
| Quarterly Earnings Growth | -0.44% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | -0.34% |
| Operating Margin (TTM) | 0.17% | 0.00% |
| Return on Equity (TTM) | -0.02% | -0.36% |
| Debt to Equity (MRQ) | 82.04 | 102.73 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $68.14 | $13.05 |
| Cash per Share (MRQ) | $3.72 | $4.53 |
| Operating Cash Flow (TTM) | $787.45M | $305.61M |
| Levered Free Cash Flow (TTM) | $706.38M | $140.26M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Charles River vs Exact Sciences
| Metric | CRL | EXAS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 681.33 | -7.33 |
| Forward P/E | 14.47 | -120.56 |
| PEG Ratio | 14.47 | -120.56 |
| Price to Sales (TTM) | 1.82 | 2.64 |
| Price to Book (MRQ) | 2.18 | 3.14 |
| Market Capitalization | ||
| Market Capitalization | $7.32B | $7.76B |
| Enterprise Value | $9.97B | $9.44B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.48 | 3.21 |
| Enterprise to EBITDA | 10.44 | 120.57 |
| Risk & Other Metrics | ||
| Beta | 1.48 | 0.93 |
| Book Value per Share (MRQ) | $68.14 | $13.05 |
Financial Statements Comparison: Charles River vs Exact Sciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CRL | EXAS |
|---|---|---|
| Revenue/Sales | $984.17M | $706.79M |
| Cost of Goods Sold | $666.44M | $206.24M |
| Gross Profit | $317.73M | $500.55M |
| Research & Development | N/A | $105.31M |
| Operating Income (EBIT) | $74.67M | $-89.76M |
| EBITDA | $184.23M | $-36.86M |
| Pre-Tax Income | $35.98M | $-100.99M |
| Income Tax | $10.10M | $224,000 |
| Net Income (Profit) | $25.88M | $-101.22M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CRL | EXAS |
|---|---|---|
| Cash & Equivalents | $229.36M | $347.13M |
| Total Current Assets | $1.51B | $1.37B |
| Total Current Liabilities | $1.05B | $502.47M |
| Long-Term Debt | $2.99B | $2.49B |
| Total Shareholders Equity | $3.24B | $2.40B |
| Retained Earnings | $1.84B | $-4.60B |
| Property, Plant & Equipment | $402.91M | $126.66M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CRL | EXAS |
|---|---|---|
| Operating Cash Flow | $130.09M | $-36.98M |
| Capital Expenditures | N/A | $-31.17M |
| Free Cash Flow | $112.37M | $-365,000 |
| Debt Repayment | $-149.39M | $-249.17M |
| Common Stock Repurchase | $-353.13M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CRL | EXAS |
|---|---|---|
| Shares Short | 2.32M | 7.47M |
| Short Ratio | 2.86 | 2.55 |
| Short % of Float | 0.05% | 0.05% |
| Average Daily Volume (10 Day) | 989,150 | 4,605,740 |
| Average Daily Volume (90 Day) | 877,473 | 3,261,747 |
| Shares Outstanding | 51.14M | 185.62M |
| Float Shares | 48.63M | 187.46M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.13% | 0.99% |
Dividend Analysis & Yield Comparison: Charles River vs Exact Sciences
| Metric | CRL | EXAS |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |